Earnings Scheduled For February 21, 2023
Companies Reporting Before The Bell
• Sohu.com (NASDAQ:SOHU) is likely to report earnings for its fourth quarter.
Morgan Stanley Upgrades Esperion Therapeutics to Equal-Weight, Announces $9 Price Target
Morgan Stanley analyst Jeffrey Hung upgrades Esperion Therapeutics (NASDAQ:ESPR) from Underweight to Equal-Weight and announces $9 price target.
Esperion Sees Q4 Net Product Revenue $14.4M to $15.1M; FY Growth 38% to 40% YoY
Esperion (NASDAQ: ESPR) today announced preliminary, unaudited fourth-quarter 2022 financial results and highlighted key upcoming anticipated milestones which represent continued execution of the Company's transformational plan.
Esperion Therapeutics Reports Sooner Than Expected Positive Data From Nexletol Trial
Esperion Therapeutics Inc’s (NASDAQ:ESPR) CLEAR Outcomes trial met its primary endpoint, demonstrating statistically significant risk reduction in MACE-4 in patients…
Earnings Scheduled For August 2, 2022
Companies Reporting Before The Bell
• Ferrari (NYSE:RACE) is expected to report quarterly earnings at $1.27 per share on revenue of $1.22 billion.
12 Health Care Stocks Moving In Friday’s After-Market Session
Gainers
Kiromic BioPharma (NASDAQ:KRBP) stock increased by 12.6% to $0.58 during Friday's after-market session. The market value of their outstanding shares is at $8.9 million.
JP Morgan Upgrades Esperion Therapeutics to Neutral
JP Morgan analyst Jessica Fye upgrades Esperion Therapeutics (NASDAQ:ESPR) from Underweight to Neutral.
Earnings Scheduled For May 3, 2022
Companies Reporting Before The Bell
• Kiniksa Pharmaceuticals (NASDAQ:KNSA) is projected to report earnings for its first quarter.
Esperion Therapeutics Earnings Conference Call Is Coming Up, Here’s What You Need To Know
Esperion Therapeutics (NASDAQ:ESPR) will host a conference call at 08:00 AM ET on May 3, 2022, to discuss Q1 2022 earnings results.
How to Attend Esperion Therapeutics (ESPR) Conference Call
Follow this link to access the live webcast.